| Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer Y Inoue, K Yoshimura, N Kurabe, T Kahyo, A Kawase, M Tanahashi, ... Oncotarget 8 (5), 8738, 2017 | 150 | 2017 |
| Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer Y Inoue, K Yoshimura, K Mori, N Kurabe, T Kahyo, H Mori, A Kawase, ... Oncotarget 7 (22), 32113, 2016 | 119 | 2016 |
| Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease Y Enomoto, Y Nakamura, TV Colby, T Johkoh, H Sumikawa, K Nishimoto, ... PLoS One 12 (6), e0180283, 2017 | 80 | 2017 |
| Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis Y Suzuki, K Yoshimura, Y Enomoto, H Yasui, H Hozumi, M Karayama, ... Scientific reports 8 (1), 14074, 2018 | 75 | 2018 |
| Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia K Yoshimura, M Kono, Y Enomoto, K Nishimoto, Y Oyama, H Yasui, ... Respiratory medicine 137, 167-175, 2018 | 61 | 2018 |
| YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer K Tsuchiya, K Yoshimura, Y Inoue, Y Iwashita, H Yamada, A Kawase, ... Oncoimmunology 10 (1), 1962656, 2021 | 60 | 2021 |
| Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease M Kono, Y Nakamura, K Yoshimura, Y Enomoto, Y Oyama, H Hozumi, ... Respiratory medicine 117, 40-47, 2016 | 41 | 2016 |
| The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis K Nishimoto, T Fujisawa, K Yoshimura, Y Enomoto, N Enomoto, ... Respirology 23 (5), 519-525, 2018 | 40 | 2018 |
| Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic … K Yoshimura, Y Inoue, M Karayama, K Tsuchiya, K Mori, Y Suzuki, ... Lung Cancer 134, 202-209, 2019 | 38 | 2019 |
| Macrophage mannose receptor CD206 predicts prognosis in community-acquired pneumonia K Tsuchiya, Y Suzuki, K Yoshimura, H Yasui, M Karayama, H Hozumi, ... Scientific reports 9 (1), 18750, 2019 | 36 | 2019 |
| Evaluation of programmed death ligand 1 (PD-L1) gene amplification and response to nivolumab monotherapy in non–small cell lung cancer Y Inoue, K Yoshimura, K Nishimoto, N Inui, M Karayama, H Yasui, ... JAMA Network Open 3 (9), e2011818-e2011818, 2020 | 30 | 2020 |
| Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy K Yoshimura, N Inui, M Karayama, Y Inoue, N Enomoto, T Fujisawa, ... Respiratory medicine case reports 20, 160-163, 2017 | 25 | 2017 |
| Lung cancer development in patients with connective tissue disease–related interstitial lung disease: a retrospective observational study Y Enomoto, N Inui, K Yoshimura, K Nishimoto, K Mori, M Kono, T Fujisawa, ... Medicine 95 (50), e5716, 2016 | 25 | 2016 |
| Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer K Yoshimura, Y Inoue, K Tsuchiya, M Karayama, H Yamada, Y Iwashita, ... Lung Cancer 141, 21-31, 2020 | 22 | 2020 |
| Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease K Yoshimura, Y Suzuki, T Uto, J Sato, S Imokawa, T Suda International Journal of Chronic Obstructive Pulmonary Disease, 1435-1445, 2016 | 22 | 2016 |
| Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non–Small Cell Lung Cancer After Nivolumab Therapy M Karayama, Y Inoue, K Yoshimura, H Hozumi, Y Suzuki, K Furuhashi, ... Journal of Immunotherapy 45 (2), 125-131, 2022 | 21 | 2022 |
| CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer K Yoshimura, Y Suzuki, Y Inoue, K Tsuchiya, M Karayama, Y Iwashita, ... Oncoimmunology 9 (1), 1746554, 2020 | 20 | 2020 |
| POLQ overexpression is associated with an increased somatic mutation load and PLK4 overexpression in lung adenocarcinoma K Shinmura, H Kato, Y Kawanishi, K Yoshimura, K Tsuchiya, Y Takahara, ... Cancers 11 (5), 722, 2019 | 20 | 2019 |
| Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer M Karayama, N Inui, Y Inoue, K Yoshimura, K Mori, H Hozumi, Y Suzuki, ... Cancer Immunology, Immunotherapy 71 (1), 203-217, 2022 | 19 | 2022 |
| WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma K Shinmura, H Kato, Y Kawanishi, H Igarashi, Y Inoue, K Yoshimura, ... Molecular Carcinogenesis 56 (8), 1984-1991, 2017 | 19 | 2017 |
